➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Harvard Business School
Johnson and Johnson
Dow
Merck

Last Updated: March 3, 2021

DrugPatentWatch Database Preview

Selegiline - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for selegiline and what is the scope of freedom to operate?

Selegiline is the generic ingredient in four branded drugs marketed by Somerset, Apotex, Lannett Co Inc, Novitium Pharma, Rising, Bausch, Apotex Inc, Boscogen, Chartwell Molecules, Cosette, G And W Labs Inc, I3 Pharms, and Mylan, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for selegiline. One supplier is listed for this compound.

Summary for selegiline
Drug Prices for selegiline

See drug prices for selegiline

Recent Clinical Trials for selegiline

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
E-Group ICT Software Informatikai Zrt.Phase 2
László MangelPhase 2
University of OxfordN/A

See all selegiline clinical trials

Medical Subject Heading (MeSH) Categories for selegiline

US Patents and Regulatory Information for selegiline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
I3 Pharms SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074672-001 Apr 1, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Chartwell Molecules SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074565-001 Aug 2, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 RX Yes No   Start Trial   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006 RX Yes Yes   Start Trial   Start Trial   Start Trial
Novitium Pharma SELEGILINE HYDROCHLORIDE selegiline hydrochloride CAPSULE;ORAL 075352-001 Nov 30, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074866-001 Nov 26, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for selegiline

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
McKesson
Medtronic
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.